Выявление генетического разнообразия Mycobacterium tuberculosis на территории стран СНГ
Диссертация
Г. Москва, Россия, 2004) — International scientific conference «Development of international collaboration in field of study infectious diseases» (г. Новосибирск, Россия, 2004) — International Conference on Chemical Biology (г. Новосибирск, Россия, 2005) — 3rd Young Medics' International Conference (г. Ереван, Армения, 2005) — Международная конференция «Фундаментальные науки — Биотехнологии… Читать ещё >
Содержание
- СПИСОК СОКРАЩЕНИЙ
- ГЛАВА 1. ОБЗОР ЛИТЕРАТУРЫ
- МОЛЕКУЛЯРНАЯ ЭПИДЕМИОЛОГИЯ ТУБЕРКУЛЕЗА
- МЕТОДЫ МОЛЕКУЛЯРНО-ГЕНЕТИЧЕСКОГО ТИПИРОВАНИЯ М. TUBERCULOSIS
- Полиморфизм длин рсстрикционных фрагментов IS6110 (RFLP-типиропание)
- Методы выявления М. tuberculosis, основанные на ПЦР
- МОЛЕКУЛЯРНЫЕ ОСНОВЫ ВОЗНИКНОВЕНИЯ УСТОЙЧИВОСТИ и МОЛЕКУЛЯРНО-ГЕНЕТИЧЕСКИЕ МЕТОДЫ ИХ ОПРЕДЕЛЕНИЯ
- ФИЛОГЕНИЯ ТУБЕРКУЛЕЗА
- ВЕТВЬ М. TUBERCULOSIS
- ДРУГИЕ ФИЛОГЕНЕТИЧЕСКИЕ ЛИНИИ M. TUBERCULOSIS COMPLEX
- ЭПИДЕМИОЛОГИЯ ТУБЕРКУЛЕЗА В РОССИИ
- СЕМЕЙСТВО BEIJING М. TUBERCULOSIS
- Молекулнрно-генетинеские признаки семейства Beijing
- Особенности патогенеза и патологической анатомии туберкулеза, вызванного штаммами генотипа Beijing
- ГЛАВА 2. МАТЕРИАЛЫ И МЕТОДЫ
- МАТЕРИАЛЫ
- МЕТОДЫ
- ГЛАВА 3. РЕЗУЛЬТАТЫ
- 1. ВЫЯВЛЕНИЕ ГЕНЕТИЧЕСКОГО РАЗНООБРАЗИЯ MYCOBACTERIUM TUBERCULOSIS
- 1. 1. Определение генетического разнообразия изолятов M. iuberculosis, циркулирующих на территории г. Харькова, Украина
- 1. 2. Определение генетического разнообразия МЛиЬегсиШ^я, циркулирующих на территории г. Астана, Казахстан
- 1. 3. Определение генетического разнообразия МЛиЬегси1оз'к, циркулирующих на территории г. Новосибирска, СФО, РФ
- 1. 4. Определение генетического разнообразия МЛиЬегсМозЬ, циркулирующих на территории г. Владивостока (ДФО, РФ)
- 1. 5. Сравнительный анализ распределения генетических профилей в исследуемых выборках
- 2. ИЗУЧЕНИЕ ЛЕКАРСТВЕННОЙ УСТОЙЧИВОСТИ К ПРОТИВОТУБЕРКУЛЕЗНЫМ ПРЕПАРАТАМ
- 2. 1. Выявление ассоциаций между наличием множественной лекарственной устойчивости и принадлежностью к тому или иному семейству
- 2. 2. Изучение частоты встречаемости мажорных мутаций, определяющих резистентное 1Ь к изониазиду и рифампицину
- 2. 3. Поиск ассоциаций между принадлежностью к определенному семейству и наличием нуклеотидной замены (ТСС→ТТС) в 531 кодоне гена гроВ
- 1. ВЫЯВЛЕНИЕ ГЕНЕТИЧЕСКОГО РАЗНООБРАЗИЯ MYCOBACTERIUM TUBERCULOSIS
Список литературы
- Brosch, R., et al., A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sei USA, 2002. 99(6): p. 3684−9.
- Tsolaki, A.G., et al., Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc Natl Acad Sei USA, 2004. 101(14): p. 4865−70.
- Sola, C., et al., Genotyping of the Mycobacterium tuberculosis complex using MIRUs: association with VNTR and spoligotyping for molecular epidemiology and evolutionary genetics. Infect Genet Evol, 2003. 3(2): p. 125−33.
- Bifani, P. J, et al., Global’dissemination of the Mycobacterium tubercidosis W-Beijing family strains. Trends Microbiol, 2002.10(1): p. 45−52.
- Mokrousov, I., et al., Origin and primary dispersal of the Mycobacterium tuberculosis Beijing genotype: clues from human phylogeography. Genome Res, 2005.15(10): p. 1357−64.
- Lopez, В., et al., A marked difference in pathogenesis and immune response induced by different Mycobacterium tubercidosis genotypes. Clin Exp Immunol, 2003. 133(1): p. 30−7.
- Brudey, K., et al., Molecular epidemiology of Mycobacterium tubercidosis in western Sweden. J Clin Microbiol, 2004. 42(7): p. 3046−51.
- Borrell, S. and S. Gagneux, Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tubercidosis Int J Tuberc Lung Dis, 2009. 13(12): p. 1456−66.
- Mathema, В., et al., Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev, 2006,-19(4): p. 658−85.
- Barnes, P.F. and M.D. Cave, Molecular epidemiology of tuberculosis. N Engl J Med, 2003. 349(12): p. 1149−56.
- Cole, S.T., et al., Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998. 393(6685): p. 537−44.
- Frothingham, R., H.G. Hills, and K.H. Wilson, Extensive DNA sequence conservation throughout the Mycobacterium tuberculosis complex. J Clin Microbiol, 1994. 32(7): p. 1639−43.
- Aranaz, A., et al., Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of a new member of the Mycobacterium tubercidosis complex isolated from goats in Spain. Int J Syst Bacteriol, 1999. 49 Pt 3: p. 1263−73.
- Cousins, D.V., et al., Tuberculosis in imported hyrax (Procavia capensis) caused by an unusual variant belonging to the Mycobacterium tuberculosis complex. Vet Microbiol, 1994. 42(2−3): p. 135−45.
- Fleischmann, R.D., et al., Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol, 2002. 184(19): p. 547 990.
- Van Soolingen, D., Molecular epidemiology of tubercidosis and other mycobacterial infections: main methodologies and achievements. J Intern Med, 2001. 249(1): p. 1−26.
- Overduin, P., et al., Use of multilocus variable-number tandem-repeat analysis for typing Mycobacterium avium subsp. paratuberculosis. J Clin Microbiol, 2004. 42(11): p. 5022−8.
- Kanduma, E., T.D. McHugh, and S.H. Gillespie, Molecular methods for Mycobacterium tuberculosis strain typing: a users guide. J Appl Microbiol, 2003.94(5): p. 781−91.
- Goguet de la Salmoniere, Y.O., et al., Evaluation*of spoligotyping in a study of the transmission of Mycobacterium tuberculosis. J Clin Microbiol, 1997. 35(9): p. 2210−4.
- Mostrom, P., et al., Methods used in the molecular epidemiology of tuberculosis. Clin Microbiol Infect, 2002. 8(11): p. 694−704.
- Kremer, K., et al., Discriminatory power and reproducibility of novel DNA typing methods for Mycobacterium tuberculosis complex strains. J Clin Microbiol, 2005. 43(11): p. 5628−38.
- Kremer, K., et al., Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol, 2004. 42(9): p. 4040−9.
- Frothingham, R. and W.A. Meeker-O'Connell, Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats. Microbiology, 1998.144 (Pt 5): p. 1189−96.
- Ed. G.F. Hatfull, W.R.J.J., Molecular Genetics of Mycobacteria Washington, D.C.: ASM Press, 2000: p. 69−84.
- Supply, P., et al., Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol, 2000. 36(3): p. 762−71.
- Mazars, E., et al., High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sei U S A, 2001. 98(4): p. 1901−6-
- Skuce, R.A., et al., Discrimination of Mycobacterium tuberculosis complex bacteria using novel VNTR-PCR targets. Microbiology, 2002. 148(Pt 2): p. 51 928.
- Allix-Beguec, C., et al., Standardised PCR-based molecidar epidemiology of tuberculosis. Eur Respir J, 2008. 31(5): p. 1077−84.
- Kwara, A., et al., Evaluation of the epidemiologic utility of secondary typing methods for differentiation of Mycobacterium tuberculosis isolates. J Clin Microbiol, 2003. 41(6): p. 2683−5.
- Ramaswamy, S. and J.M. Musser, Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis, 1998. 79(1): p. 3−29.
- Baylan, O.', Extensively Drug Resistant and Extremely Drag Resistant Tuberculosis Forms’After Multi-Drug Resistant Tubercidosis: New Faces of the Old Disease. Mikrobiyol Bui. 45(1): p. 181−195.
- Telenti, A., et al., Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 1993. 341(8846): p. 647−50.
- Musser, J.M., Antimicrobial agent resistance in mycobacteria: molecular j genetic insights. Clin Microbiol Rev, 1995. 8(4): p. 496−514. i
- Donnabella, V., et al., Isolation of the gene for the beta subunit of RNA ' polymerase from rifampicin-resistant Mycobacterium tubercidosis and identification of new mutations. Am J Respir Cell Mol Biol, 1994. 11(6): p. 63 943.
- Altamirano, M., et al., Mutations in the catalase-peroxidase gene from isoniazid-resistant Mycobacterium tuberculosis isolates. J Infect Dis, 1994. 169(5): p. 1162−5.
- Wengenack, N.L., et al., Recombinant Mycobacterium tuberculosis KatG (S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J Infect Dis, 1997. 176(3): p. 722−7.
- Voronina, E.N., et al., KatG Ser3 15Thr mutation as the main reason of isoniazid resistance in Mycobacterium tuberculosis isolated in the Novosibirsk and Kemerovo Regions. Mol Gen Mikrobiol Virusol, 2004(3): p. 8−11.
- Дымова M.A., Н.С.Д., Акулинушкин.А.И., Огиренко А. П., Филипенко M.JI., Преобладание Mycobacterium tuberculosis семейства Beijing у больных с тяжелыми формами туберкулеза. Вестник НГУ: Биология, клинич. мед., 2008. Т. 6(3): р. С. 106−109.
- Cockerill, F.R., 3rd, et al., Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance. J Infect Dis, 1995. 171(1): p. 240−5.
- Johnsson, K., W.A. Froland, and P.G. Schultz, Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis. J Biol Chem, 1997. 272(5): p. 2834−40.
- Loevven, P.C., et al., Molecular characterization of three mutations in katG affecting the activity of hydroperoxidase I of Escherichia coli. Biochem Cell Biol, 1990. 68(7−8): p. 1037−44.
- Pelletier, H. and J. Kraut, Crystal structure of a complex between electron transfer partners, cytochrome c peroxidase and cytochrome c. Science, 1992. 258(5089): p. 1748−55.
- Basso, L.A., et al., Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates. J Infect Dis, 1998. 178(3): p. 769−75.
- Banerjee, A., et al., inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science, 1994. 263(5144): p. 22 730.
- Deretic, V., et al., Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Mol Microbiol, 1995.17(5): p. 889−900.
- Sherman, D.R., et al., Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. Proc Natl Acad Sei USA, 1995. 92(14): p. 6625−9.
- Wilson, T.M. and’D.M. Collins, ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol Microbiol, 1996. 19(5): p. 102 534.
- Ramaswamy, S.V., et al., Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2003. 47(4): p. 1241−50.
- Alland, D., et al., Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition. J Bacteriol, 2000.182(7): p. 1802−11.
- Wilson, M., et al., Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sei U S A, 1999. 96(22): p. 12 833−8.
- Miesel, L., et al., NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis. J Bacteriol, 1998. 180(9): p. 2459−67.
- Payton, M., et al., Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. J Bacteriol, 1999.181(4): p. 1343−7.
- Upton, A.M., et al., Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism. Mol Microbiol, 2001. 42(2): p. 309−17.
- Argyrou, A., et al., Mycobacterium. tuberculosis dihydrofolate reductase is a target for isoniazid. Nat Struct Mol Biol, 2006.13(5): p. 408−13.
- Ho, Y.M., et al., Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother, 2009. 53(9): p. 4010−2.
- Pagan-Ramos, E., et al., Oxidative stress response and characterization of the oxyR-ahpC and furA-katG loci in Mycobacterium marinum. J Bacteriol, 1998. 180(18): p. 4856−64.
- Pym, A.S., B. Saint-Joanis, and S.T. Cole, Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun, 2002. 70(9): p. 4955−60.
- Rouse, D.A., et al., Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazidresistance. Mol Microbiol, 1996. 22(3): p. 583−92.
- Jiao, W.W., et al., Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin Med J (Engl), 2007.120(9): p. 814−9.
- Bakonyte, D, et al., Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob Agents Chemother, 2003. 47(6): p. 2009−11.
- Zhang, M., et al., Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J Clin Microbiol, 2005. 43(11): p. 5477−82.
- Cardoso, R.F., et al., Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob Agents Chemother, 2004. 48(9): p. 3373−81.
- Kelley, C.L., D.A. Rouse, and S.L. Morris, Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother, 1997. 41(9): p. 2057−8.
- Lee, A.S., A.S. Teo, and S.Y. Wong, Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother, 2001. 45(7): p. 2157−9.
- Billington, O.J., T.D. McHugh, and S.H. Gillespie, Physiological cost of rifampin resistance induced in vitro in Mycobacterium tubercidosis. Antimicrob Agents Chemother, 1999. 43(8): p. 1866−9.
- Gagneux, S., et al., The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science, 2006. 312(5782): p. 1944−6.
- Cohen, T. and M. Murray, Modeling epidemics of multidrug-resistant M. tubercidosis of heterogeneous fitness. Nat Med, 2004. 10(10): p. 1117−21.
- Burgos, M., et al., Effect of drug resistance on the generation of secondary cases of tuberculosis. J Infect Dis, 2003.188(12): p. 1878−84.
- Dubiley, S., E. Kirillov, and A. Mirzabekov, Polymorphism analysis and gene detection by minisequencing on an array of gel-immobilized primers. Nucleic Acids Res, 1999. 27(18): p. el9.
- Pretorius, G.S., et al., Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare. Antimicrob Agents Chemother, 1995. 39(10): p. 2276−81.
- Felmlee, T.A., et al., Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxyfingerprinting. J Clin Microbiol, 1995. 33(6): p. 1617−23.
- Hazbon, M.H., Recent advances in molecular methods for early diagnosis of tuberculosis and drug-resistant tuberculosis. Biomedica, 2004. 24 Supp 1: p. 149−62.
- El-Hajj, H.H., et al., Detection of rifampin resistance in Mycobacterium tubercidosis in a single tube with molecular beacons. J Clin Microbiol, 2001. 39(11): p. 4131−7.
- Troesch, A., et al., Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol, 1999. 37(1): p. 49−55.
- Brow, M.A., et al., Differentiation of bacterial 16S rRNA genes and intergenic regions and Mycobacterium tuberculosis katG genes by structure-specific endonuclease cleavage. J Clin Microbiol, 1996. 34(12): p. 3129−37.
- Agaev, F.F., et al., Molecular genetic and bacteriological methods for the diagnosis of multidrug resistant M. tuberculosis. Probl Tuberk Bolezn Legk, 2009(9): p. 32−5.
- Nachamkin, I., C. Kang, and M.P. Weinstein, Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin Infect Dis, 1997. 24(5): p. 894−900.
- Gagneux, S. and P.M. Small, Global phylogeography of Mycobacterium tuberculosis and implications for tubercidosis product' development. Lancet Infect Dis, 2007. 7(5): p. 328−37.
- Mahairas, G.G., et al., Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol, 1996. 178(5): p. 1274−82.
- Gordon, S.V., et al., Genomics of Mycobacterium bovis. Tuberculosis (Edinb), 2001. 81(1−2): p. 157−63.
- Philipp, W.J., et al., Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis. Microbiology, 1996. 142 (Pt 11): p. 3135−45.
- Behr, M.A., et al., Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science, 1999. 284(5419): p. 1520−3.
- Chen, J., et al., Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls. BMC Infect Dis. 10: p. 273.
- Behr, M.A. and S. Mostowy, Molecular tools for typing and branding the tubercle bacillus. Curr Mol Med, 2007. 7(3): p. 309−17.
- Gordon, S.V., et al., Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol, 1999. 32(3): p. 643−55.
- Kato-Maeda, M., et al., Comparing genomes within the species Mycobacterium tuberculosis. Genome Res, 2001.11(4): p. 547−54.
- Sampson, S., et al., IS6110 insertions in Mycobacterium tubercidosis: predominantly into coding regions. J Clin Microbiol, 2001. 39(9): p. 3423−4.
- Hovav, A.H., et al., The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Thl-type immune response deleterious to protection. Infect Immun, 2003. 71(6): p. 3146−54.
- Parsons, L. M, et al., Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis. J. Clin Microbiol, 2002. 40(7): p. 2339−45.
- Mokrousov, I., et al., At Baltic crossroads: a molecular snapshot of Mycobacterium tuberculosis population diversity in Kaliningrad, Russia. FEMS Immunol Med Microbiol, 2009. 55(1): p. 13−22.
- Baker, L., et al., Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis. Emerg Infect Dis, 2004.10(9): p. 1568−77.
- Gagneux, S., et al., Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sei USA, 2006. 103(8): p. 2869−73.
- Brudey, K., et al., Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol, 2006. 6: p. 23.
- Ernst, J.D., G. Trevejo-Nunez, and N. Banaiee, Genomics and the evolution, pathogenesis, and diagnosis of tuberculosis. J Clin Invest, 2007. 117(7): p. 1738−45.107.108.109.110. 111.112.113.114.115.116.117.118.
- Rothschild, B.M., et al., Mycobacterium tuberculosis complex DNA from an extinct bison dated 17,000 years before the present. Clin Infect Dis, 2001. 33(3): p. 305−11.
- Bruford, M.W., D.G. Bradley, and G. Luikart, DNA markers reveal the complexity of livestock domestication. Nat Rev Genet, 2003. 4(11): p. 900−10.
- Andersen, P. and T.M. Doherty, The success and failure of BCG implications for a novel tuberculosis vaccine. Nat Rev Microbiol, 2005. 3(8): p. 656−62.
- Fine, P.E., Variation in protection by BCG: implications of andfor heterologous immunity. Lancet, 1995. 346(8986): p. 1339−45.
- Mostowy, S., et al., Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. J Infect Dis, 2002.186(1): p. 74−80.
- Shaginian, I.A., et al., Genomic polymorphism in Mycobacterium tuberculosis strains. Zh Mikrobiol Epidemiol Immunobiol, 1996(3): p. 65−8.
- Perelman, M.I., Tuberculosis in Russia. Int J Tuberc Lung Dis, 2000. 4(12): p. 1097−103.
- Stepanshina, V.N., et al., Drug-resistant strains of Mycobacterium tuberculosis isolated in Russia. Int J Tuberc Lung Dis, 1999. 3(2): p. 149−52.
- Marttila, H.J., et al., pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia. Antimicrob Agents Chemother, 1999. 43(7): p. 1764−6.
- Mikhailovich, V., et al., Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips. J Clin Microbiol, 2001. 39(7): p. 2531−40.
- Mokrousov, I., et al., High prevalence of KatG Ser315Thr substitution amongi isoniazid-resistant Mycobacterium tuberculosis clinical isolates from< northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother, 2002. 46(5): p. 1417−24.
- Toungoussova, O.S., et al., Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol, 2002. 40(6): p. 1930−7.
- Drobniewski, F., et al., Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the beijing strain family. Emerg Infect Dis, 2002. 8(11): p. 1320−6.
- Matrakshin, A.G., et al., Genotypic characteristics of Mycobacterium tuberculosis strains from the Republic of Tyva. Probl Tuberk Bolezn Legk, 2004(3): p. 37−40.
- Mokrousov, I., et al., PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circidating in Russia. Eur J Clin Microbiol Infect Dis, 2003. 22(6): p. 342−8.
- Toungoussova, S., et al., Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pidmonary tuberculosis in Archangels, Russia. Int J Tuberc Lung Dis, 2002. 6(5): p. 406−14.
- Tungusova, O.S., et al., Drug resistance of Mycobacterium tuberculosis of the genotype Beijing in imprisonment places in the Arkhangelsk Region. Probl Tuberk Bolezn Legk, 2004(8): p. 35−41.
- Drobniewski, F., et al., Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. Jama, 2005. 293(22): p. 272 631.
- Surikova, O.V., et al., Efficient differentiation of Mycobacterium tuberculosis strains of the W-Beijing family from Russia using highly polymorphic VNTR loci. Eur J Epidemiol, 2005. 20(11): p. 963−74.
- Mokrousov, I., et al., Mycobacterium tuberculosis Beijing genotype in Russia: in search of informative variable-number tandem-repeat loci. J Clin Microbiol, 2008. 46(11): p. 3576−84.
- Migliori, G.B., et al., Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. Eur Respir J, 2008. 31(6): p. 1155−9.
- Milan- S.J., et al., Expanded geographical distribution of the N family of Mycobacterium tuberculosis strains within the United States. J Clin Microbiol, 2004. 42(3): p. 1064−8:
- Kruuner, A., et al., Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol, 2001. 39(9): p. 3339−45.
- Rindi, L., et al., Evolutionary pathway of the Beijing lineage of Mycobacterium tuberculosis based on genomic deletions and mutT genes polymorphisms. Infect Genet Evol, 2009. 9(1): p. 48−53.
- Beijing/W genotype Mycobacterium tubercidosis and drug resistance. Emerg Infect Dis, 2006. 12(5): p. 736−43.
- Balabanova, Y., Drobniewski, F., Fedorin, I. et al., The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation Respir. Res., 2006. 7(1): p. 53−44.
- Jou, R., C.Y. Chiang, and W.L. Huang, Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan. J Clin Microbiol, 2005. 43(1): p. 95−100.
- Almeida, D., et al., High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tubercidosis in a tertiary care center in Mumbai, India. Clin Infect Dis, 2005. 40(6): p. 881−6.
- Malik, A.N. and P. Godfrey-Faussett, Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. Lancet Infect Dis, 2005. 5(3): p. 174−83.144.145.146.147.148.149.150.151.152.153.154.155.
- Glynn, J.R., et al., Mycobacterium tuberculosis Beijing genotype, northern Malawi. Emerg Infect Dis, 2005. 11(1): p. 150−3.
- Manca, C., et al., Hypervirulent M. tuberculosis W/Beijing strains upregidate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J Interferon Cytokine Res, 2005. 25(11): p. 694−701.
- Abebe, F. and G. Bjune, The emergence of Beijing family genotypes of Mycobacterium tubercidosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link? Clin Exp Immunol, 2006: 145(3): p. 389−97.
- Chacon-Salinas, R., et al., Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes. Clin Exp Immunol, 2005.140(3): p. 443−9.
- McShane, H., Susceptibility to tuberculosis—the importance of the pathogen as well as the host. Clin Exp Immunol, 2003.133(1): p. 20−1.
- Manca, C., et al., Differential monocyte activation underlies strain-specific Mycobacterium tubercidosis pathogenesis. Infect Immun, 2004. 72(9): p. 55 114.
- Parwati, I., R. van Crevel, and D. van Soolingen, Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis, 2010. 10(2): p. 103−11.
- Anh, D.D., et al., Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis, 2000. 6(3): p. 302−5.
- Li, Q., et al., Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infect Immun, 2002. 70(11): p. 6489−93.
- Borgdorff, M.W., et al., Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis (Edinb), 2004. 84(5): p. 337−40.
- Sun, Y.J., et al., Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison. BMC Infect Dis, 2006. 6: p. 105.
- Sun, Y.J., et al., Association of Mycobacterium tuberculosis Beijing genotype with tuberculosis relapse in Singapore. Epidemiol Infect, 2006. 134(2): p. 32 932.
- Kocagoz, Т., et al., Detection of Mycobacterium tuberculosis in sputum samples by polymerase chain reaction using a simplified procedure. J Clin Microbiol, 1993. 31(6): p. 1435−8.
- Supply, P., et al., Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol, 2006. 44(12): p. 4498−510.
- Benson, G., Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res, 1999. 27(2): p. 573−80.
- Drobniewski, F.A. and S.M. Wilson, The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis—a molecular story. J Med Microbiol, 1998. 47(3): p. 189−96.
- Nikolayevskyy, V.V., et al., Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine. Clin Microbiol Infect, 2007. 13(2): p. 129−38.
- Bumburidi, E., et al., Progress toward tubercidosis control and determinants of treatment outcomes—Kazakhstan, 2000−2002. MMWR Morb Mortal Wkly Rep, 2006. 55 Suppll: p. 11−5.
- Mokrousov, I., et al., Penitentiary population of Mycobacterium tuberculosis in Kyrgyzstan: exceptionally high prevalence of the Beijing genotype and its Russia-specific subtype. Infect Genet Evol, 2009. 9(6): p. 1400−5.
- Kubica, Т., et al., The Beijing genotype is a major cause of drug-resistant tuberculosis in Kazakhstan. Int J Tuberc Lung Dis, 2005. 9(6): p. 646−53.
- Hillemann, D., et al., Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. Int J Tuberc Lung Dis, 2005. 9(10): p. 1161−7.
- Murashkina G.S., A.T.V., Novikova N.M., Silaikina S.T., Reviakina O.V." Antituberculosis measures in the Siberian and Far Eastern Federal Districts in Figures. Novosibirsk Research Institute of Tuberculosis., 2010.
- Lillebaek, Т., et al., Mycobacterium tuberculosis Beijing genotype. Emerg Infect Dis, 2003. 9(12): p. 1553−7.
- Lari, N., et al., Beijing/W Mycobacterium tuberculosis in Italy Emerg Infect Dis, 2004. 10(5): p. 958−9.
- Caminero, J.A., et al., Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island Am J Respir Crit Care Med, 2001. 164(7): p. 1165−70.
- Zhou, A., et al., Molecular genotyping of Mycobacterium tuberculosis in XVan, China, usingMIRU-VNTR typing. Int J Tuberc Lung Dis. 15(4): p. 517−22.
- Татьков С.И., С.А.Ю., Кузьмичева Г. А., Смирнова О.Ю., Филипенко М. Л., Рот М. А., Свистельник A.B., Лисиченко Г. М., Краснов В. А., Eisenach K.D., ч
- Wang, J., et al., Genotypes and Characteristics of Clustering and Drug Susceptibility of Mycobacterium tuberculosis Isolates Collected in Heilongjiang Province, China. J Clin Microbiol. 49(4): p. 1354−62.
- Шемякин И.Г., С.В.Н., Коробова О. В., Анисимова В. А., Генетическое типирование штаммов Mycobacterium Tuberculosis методами сполиготипирования и геномной дактилоскопии. Журнал Микробиологии, Эпидемиологии и Иммунологии, 2003(№ 2): р. 30 35.
- Kurepina, N.E., et al., Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region Tuber Lung Dis, 1998. 79(1): p. 31−42.
- Medvedeva, T.V., et al., MIRU-VNTR genotyping of Mycobacterium tuberculosis strains from East Siberian: Beijing family versus Kilimanjaro family. Mol Gen Mikrobiol Virusol, 2004(4): p. 33−8.
- Kovalev, S.Y., et al., Genetic analysis of mycobacterium tuberculosis strains isolated in Ural region, Russian Federation, by MIRU-VNTR genotyping. Int J Tuberc Lung Dis, 2005. 9(7): p. 746−52.
- Niemann- S., et al., Mycobacterium tubercidosis Beijing lineage favors the spread of multidrug-resistant tubercidosis in the Republic of Georgia. J Clin Microbiol. 48(10): p. 3544−50.
- Sola, C., et al., Mycobacterium tuberculosis molecular evolution in western Mediterranean Islands of Sicily and Sardinia. Infect Genet Evol, 2005. 5(2): p. 145−56^
- Lee, A.S., et al., Contribution ofkasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob Agents Chemother, 1999. 43(8): p. 2087−9.
- Piatek, A.S., et al., Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother, 2000. 44(1): p. 103−10.
- Fang, Z., et al., Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997). J Clin Microbiol, 1999. 37(4): p. 998−1003.
- Marttila, H.J., et al., katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob Agents Chemother, 1996. 40(9): p. 2187−9.
- Dobner, P., et al., Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isoniazid resistance. Int J Tuberc Lung Dis, 1997. 1(4): p. 365−9.
- Escalante, P., et al., Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. Tuber Lung Dis, 1998. 79(2): p. 111−8.
- Taniguchi, H., et al., Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett, 1996. 144(1): p. 103−8.
- Bodmer, T., et al., Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. J Antimicrob Chemother, 1995. 35(2): p. 345−8.
- Ohno, H., et al., Relationship between rifampin MICsfor and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother, 1996. 40(4): p. 1053−6.
- Zhou, Y.N. and D.J. Jin, The rpoB mutants destabilizing initiation complexes at stringently controlled promoters behave like «stringent» RNA polymerases in Escherichia coll Proc Natl Acad Sei USA, 1998. 95(6): p. 2908−13.
- Mokrousov, I., et al., Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears. Antimicrob Agents Chemother, 2003. 47(7): p. 2231−5.
- Tracevska, T., et al'., Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol, 2002. 40(10): p. 3789−92.
- Van Rie, A., et al., Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tubercidosis in a high-incidence community. J Clin Microbioh, 2001. 39(2): p. 636−41.
- Mokrousov, I., et al., Evaluation of the rpoB macroarray assay to detect rifampin resistance in Mycobacterium tuberculosis in Beijing, China. Eur J Clin Microbiol Infect Dis, 2006. 25(11): p. 703−10.
- Tracevska, T., et al., Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis, 2003. 7(11): p. 1097−103.
- Ebrahimi-Rad, M., et al., Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis, 2003. 9(7): p. 838−45.
- Lari, N., et al., Mutations in mutT genes of Mycobacterium tubercidosis isolates of Beijing genotype. J Med Microbiol, 2006. 55(Pt 5): p. 599−603.
- Werngren, J. and S.E. Hoffher, Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate. J Clin Microbiol, 2003. 41(4): p. 1520−4.
- Gillespie, S.H., Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother, 2002. 46(2): p. 267−74.
- Ignatova, A., et al., Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia. J Med Microbiol, 2006. 55(Pt 10): p. 1413−8.
- Toungoussova, O.S., et al., Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clin Infect Dis, 2003. 37(5): p. 665−72.
- Qian, L., et al., rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries. J Clin Microbiol, 2002. 40(3): p. 1091−4.